Tel: +91 124 2821030
Email: info@windlasbiotech.com
Home
About
Our Heritage
EXPERTISE
Our Mission & Vision
Services
Products
Our Brands
Investor Relations
Financial Information
Annual Financials
Quarterly Results
Investor Presentation
Quarterly Results Press Release
Earnings Call Transcript
Audio Transcript
Earnings Conference Call Transcript
Annual Report
Buy Back of Shares
Public Announcement
Daily Reporting
Extinguishment of Shares
Corporate Governance
Committee Composition
List of Directors
Independent Directors
Management Team Information
Code of Conduct
Policies
Annual Return
Credit Rating
Investor Information
Company Fact Sheet
Share Holding Pattern
Stock Prices
Unclaimed dividend
Corporate Announcement
Notice of Board Meeting
Stock Exchange Communication
Monitoring Agency
Statement of Deviation
Secretarial Compliance Report
Schedule of Analyst
Published in Newspaper
Investor Contact
Compliance Officer
Investor Relations
Registrar
Grievance Officer
Contact For Material Event
CSR
Career
Contact
X
Contact us
Annual Financials
ANNUAL FINANCIALS
Financial results available for the following years:
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
AUDITED CONSOLIDATED IND AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2023
AUDITED CONSOLIDATED IND AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2022
WINDLAS INC FY 22
AUDITED STANDALONE INS AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2022
AUDITED CONSOLIDATED IND AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2021
AUDITED STANDALONE INS AS FINANCIAL STATEMENTS WITH AUDIT REPORT AS ON 31.03.2021
WINDLAS INC
WINDLAS BIOTECH
WINDLAS HEALTHCARE
WINDLAS INC
US PHARMA INC
WINDLAS BIOTECH
WINDLAS HEALTHCARE
WINDLAS INC
US PHARMA INC
WINDLAS BIOTECH
WINDLAS HEALTHCARE
WINDLAS INC
US PHARMA INC
